Home » Newsletters » BioWorld Science

BioWorld Science

May 19, 1998

View Archived Issues

Company Profile: ZymeTx

Batimastat enhances antitumor activity of cisplatin against ovarian cancer

Postmarketing evaluation of Clozaril may lead to increased patient availability

Biovector licenses DNA delivery technology from NIH

Matrix proceeds with full enrollment for IntraDose phase II trials

Antiherpes agent will enter phase II, Abbott says

Safety and pharmacokinetic data reported for MEDI-507

Company Profile: IGT Pharma

Phytera signs R&D and marketing agreement with NeuroSearch

Rivastigmine ameliorates immediate and long-term sequelae of closed-head injury

Gilead: Q1 1998 highlights

Interneuron: Q2 1998 highlights

Helopharm describes improved class III antiarrhythmic agents

Oral antiinflammatory/analgesic compounds with reduced ulcerogenic potential

Neuroprotective heterocyclic compounds developed at Cambridge NeuroScience

IL-8 receptor antagonists described by SKB

Glaxo Wellcome introduces anti-HIV combination product in U.K.

Somatostatin analogue launched in U.K.

New PDE IV inhibitors from Euroceltique

Spotlight on treatment and prevention of C. difficile infection

Phase I toxicity and efficacy results for CT-2584 presented at ASCO meeting

Cytokine suppressants: an effective approach to the treatment of cancer cachexia

Cor's fibrinogen antagonist on the way to market

Leuvectin proceeds to phase II for renal cell carcinoma

Neurocrine Biosciences initiates clinical-stage development of IL-4 fusion toxin

C225 + radiotherapy produces 100% response rate in head and neck cancer

Helicase-primase, an enzyme target for the design of new antiviral agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...